S100B and hepatocellular carcinoma: Based on these pilot studies, the serological assessment of S100 proteins, in association with the detection of α-fetoprotein, an accurate marker of HCC with high specificity but poor sensitivity [168], should importantly complement the clinical arsenal of diagnostic/prognostic tools for HCC.